Oral contraceptives: a review of certain metabolic effects and an examination of the question of safety.
D000568:Amenorrhea / Q000139:chemically induced; D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced; D002118:Calcium / Q000378:metabolism; D050260:Carbohydrate Metabolism; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004717:Endometrium; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D006801:Humans; D008099:Liver / Q000502:physiology; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D009584:Nitrogen / Q000378:metabolism; D010048:Ovarian Cysts / Q000139:chemically induced; D010710:Phosphates / Q000378:metabolism; D011247:Pregnancy; D013923:Thromboembolism / Q000139:chemically induced*; D013924:Thrombophlebitis / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced
D003276:Contraceptives, Oral; D004967:Estrogens; D010710:Phosphates; D009584:Nitrogen; D002118:Calcium